## HON: Honeywell International Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.6% below STRENGTH zone (4.0-10.0%); PEG 1.80 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($192.55)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Honeywell International (HON) Stock on Dec. 18, 2025: Latest News, Analyst Forecasts, and What’s Next**
- Source: ts2.tech | 20251218T210959 | Somewhat-Bullish | Relevance: 100%
- Honeywell International (HON) stock is seeing increased attention on December 18, 2025, due to new analyst coverage and its ongoing corporate transformation. The company's Solstice Advanced Materials spin-off is complete, and a larger Aerospace separation is planned for late 2026, aiming to create three focused public companies. While the stock has seen muted movement, analysts are debating its upside potential given these strategic shifts and emerging themes like "AI + electrification industrials."

**2. Honeywell (HON): Revisiting Valuation After Positive Evercore Coverage and Ongoing Portfolio Transformation**
- Source: Simply Wall Street | 20251218T200001 | Bullish | Relevance: 100%
- Honeywell (HON) has received positive attention following Evercore ISI's upbeat coverage and significant portfolio transformations, including high-profile technology partnerships. Despite a recent share price increase of 4.08% over seven days, the stock is down 11.36% year-to-date, though its 5-year return shows steady compounding. The company is considered 16.5% undervalued with a fair value of $239.40, driven by growth in high-demand verticals and productivity improvements, although execution risks exist.

**3. Honeywell (HON) Stock After Hours on Dec. 17, 2025: What Happened After the Bell and What to Watch Before Thursday’s Open**
- Source: ts2.tech | 20251218T031125 | Somewhat-Bullish | Relevance: 100%
- Honeywell (HON) stock showed resilience on December 17, 2025, closing higher than the broader market and inching up in after-hours trading. The company's performance is driven by its ongoing transformation, including the Solstice spin-off and the planned separation of Aerospace and Automation businesses in H2 2026. Investors are now focused on Thursday's macro catalyst, specifically the U.S. Consumer Price Index (CPI) release, which will likely dictate market sentiment and HON's short-term price action.

**4. Honeywell (HON) Stock News & Forecast Today: Evercore’s $255 Target Puts 2026 Breakup Catalysts Back in Focus (Dec. 17, 2025)**
- Source: ts2.tech | 20251217T203359 | Somewhat-Bullish | Relevance: 100%
- Honeywell (HON) is gaining attention due to new Wall Street commentary and ongoing corporate transformation. Evercore ISI initiated coverage with an Outperform rating and a $255 price target, highlighting Honeywell's exposure to industrial cycles and its potential 2026 market leadership shift. The company is actively pursuing a multi-year strategy to break into more focused, standalone businesses, with key milestones like the Solstice Advanced Materials spin-off already completed and the Aerospace spin-off on track for H2 2026.

**5. Honeywell (HON) positioned for earnings momentum into FY26, says Evercore**
- Source: MSN | 20251217T190941 | Bullish | Relevance: 100%
- Evercore ISI has updated its financial models for Honeywell, positioning the company for strong earnings momentum extending into fiscal year 2026. The firm expects continued growth and profitability for Honeywell based on their detailed analysis.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Evercore ISI Gr | $255 | $0 | 0% |
| 2025-12-04 | Barclays | $269 | $270 | -0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Evercore ISI Gr | init | Outperform |
| 2025-12-04 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 6 ($0.12M) |
| Sells | 6 ($0.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 8.9% (-0.3%)
- Blackrock Inc.: 7.1% (+6.1%)
- State Street Corpora: 4.4% (-0.8%)
- JPMORGAN CHASE & CO: 3.0% (+112.5%)
- Morgan Stanley: 2.7% (+0.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.80 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 35%, margin 15%). Balance sheet: $2.9B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $134.2B |
| Beta | 0.95 |
| 52W Range | $169.05 - $227.82 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.80 |
| Forward P/E | 18.9 |
| Current P/E | 18.7 |
| YoY Growth | -0.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 2.6% (minimal 5-day change). Below STRENGTH zone by 1.4pp (needs >4.0% for momentum thesis). MRS_5 (-0.9%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.98x), long-term trend not supportive. MACD histogram positive (1.05), confirming momentum. RSI neutral at 59. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: -DBH (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.64% (CS: 74) | Neutral |
| RSI_14 | 59.2 | Neutral |
| MACD Histogram | 1.05 | Bullish |
| vs SMA20 | 1.030x | Above |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 0.985x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $199.11
- **Stop Loss:** $192.55 (3.3% risk)
- **Target:** $205.67 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 137
- **Position Value:** $27,278.07
- **Portfolio %:** 27.28%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-05 (Est: $2.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.57 | $2.82 | +9.9% |
| 2025Q2 | $2.66 | $2.75 | +3.4% |
| 2025Q1 | $2.21 | $2.51 | +13.6% |
| 2024Q4 | $2.35 | $2.47 | +5.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*